DOI:
10.1055/s-00000030
Der Klinikarzt
LinksClose Window
References
Nomura H, Aoki D, Michimae H. et al.
A randomized phase III trial of docetaxel plus cisplatin or paclitaxel plus
carboplatin compared with doxorubicin plus cisplatin as adjuvant chemotherapy
for endometrial cancer at high risk of recurrence: Japanese Gynecologic Oncology
Group study (JGOG2043).
J Clin Oncol 2017;
35 (15_suppl) 5503-5503
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.